Publications
Advising the Biotech company, Rimbarlat, on the entry of BIHUB in its shareholding to revolutionise muscle recovery in elite athletes
The Barça Innovation Hub (BIHUB) has become a shareholder of Rimbarlat, a biotechnology company which is developing a therapy for accelerating muscle regeneration times in the injuries of elite athletes
The project of the start-up will enter clinical trials in the coming months and, thanks to the agreement, will be able to use the facilities and equipment of FC Barcelona's medical services. The new therapy has demonstrated a potential reduction of up to 50% in recovery time in the initial phases of the study.
The team led by Antoni Rosselló, Partner of the Innovation and Entrepreneurship Area, advised Rimbarlat in this transaction.
